Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension

International Journal of Biological Sciences

Volumn 10, Issue 4, 2014, Pages 386-395

  Chen, Wei ^a   Liu, De Jun ^a   Huo, Yan Miao ^a   Wu, Zhi Yong ^a   Sun, Yong Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hypocontractility; Mesenteric artery; Norepinephrine; Portal hypertension; Reactive oxygen species

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; BETA ARRESTIN; HYDROGEN PEROXIDE; NORADRENALIN; PYRIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RETINA S ANTIGEN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROCK1 PROTEIN, RAT;

ANIMAL; DRUG EFFECTS; GENETICS; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERY; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL HYPERTENSION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

AMIDES; ANIMALS; ARRESTINS; HYDROGEN PEROXIDE; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; OXIDATIVE STRESS; PYRIDINES; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84897041873     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8081     Document Type: Article

References (47)

1. Khaderi S, Barnes D. Preventing a first episode of esophageal variceal hemorrhage. Cleve Clin J Med 2008; 75: 235-244.
2. Hennenberg M, Trebicka J, Biecker E, et al. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology 2007; 45: 495-506.
3. Hennenberg M, Trebicka J, Kohistani AZ, et al. Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis. Eur J Clin Invest 2009; 39: 906-913.
4. Chen W, Sang JY, Liu DJ, et al. Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mes-enteric arteries of cirrhotic patients and rats. Hepatobiliary Pancreat Dis Int 2013; 12: 295-304
5. Heller J, Trebicka J, Shiozawa T, et al. Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis. Liver Int 2005; 25: 657-666.
6. Møller S, Bendtsen F, Henriksen JH. Determinants of the ren-in-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume. Scand J Gastroenterol 2006; 41: 451-458.
7. Touyz RM. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 2003; 1: 91-106.
8. Fernando B, Marley R, Holt S, et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 1998; 28: 689-694.
9. Ferlitsch A, Pleiner J, Mittermayer F, et al. Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites. Crit Care Med 2005; 33: 2028-2033.
10. Dal-Ros S, Oswald-Mammosser M, Pestrikova T, et al. Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mes-enteric artery in rats. Gastroenterology 2010; 138: 1574-1584.
11. Jernigan NL, Walker BR, Resta TC. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2008; 295: L515-L529.
12. Jackson EK, Gillespie DG, Zhu C, et al. Alpha2-adrenoceptors enhance angio-tensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension 2008; 51: 719-726.
13. Tsai MH, Jiang MJ. Reactive oxygen species are involved in regulating alpha1-adrenoceptor-activated vascular smooth muscle contraction. J Biomed Sci 2010; 17: 67.
14. Miller AA, Budzyn K, Sobey CG. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin Sci (Lond) 2010; 119: 1-17.
15. Sousa T, Pinho D, Morato M, et al. Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 2008; 588: 267-276.
16. Angermayr B, Fernandez M, Mejias M, et al. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Gut 2007; 56: 560-564.
17. Yuksel BC, Serdar SE, Tuncel A, et al. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock. Eur Surg Res 2009; 43: 219-227.
18. Cuzzocrea S, McDonald MC, Mazzon E, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Critl Care Med 2001; 29: 102-111.
19. Falcone JC, Kuo L, Meininger GA. Endothelial cell calcium increases during flow-induced dilation in isolated arterioles. Am J Physiol 1993; 264(2 Pt 2): H653-H659.
20. Ejiri J, Inoue N, Tsukube T, et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 2003; 59: 988-996.
21. Trebicka J, Leifeld L, Hennenberg M, et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 2008; 47: 1264-1276.
22. Zhou Q, Hennenberg M, Trebicka J, et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006; 55: 1296-1305.
23. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005; 65: 16-27.
24. De Keulenaer GW, Alexander RW, Ushio-Fukai M, et al. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998; 329: 653-657.
25. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 2003; 278: 12094-12100.
26. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacolo Sci 2003; 24: 471-478.
27. Grote K, Flach I, Luchtefeld M, et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003; 92: e80-e86.
28. Vercelino R, Tieppo J, Dias AS, et al. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin Pharmacol Toxicol 2008; 102: 370-376.
29. Lee KC, Yang YY, Wang YW, et al. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, en-dotoxin, and portal pressure. Dig Dis Sci 2010; 55: 2077-2085.
30. Chen MF, Mo LR, Lin RC, et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med 1997; 23: 672-679.
31. Mitchell JB, Samuni A, Krishna MC, et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990; 29: 2802-2807
32. Guillaume M, Rodriguez-Vilarrupla A, Gracia-Sancho J, et al. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats. J Hepatol 2013; 58: 240-246.
33. Garcia-Caldero H, Rodriguez-Vilarrupla A, Gracia-Sancho J, et al. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. J Hepatol 2011; 54(4): 660-665.
34. Yada T, Shimokawa H, Morikawa K, et al. Role of Cu,Zn-SOD in the synthesis of endogenous vasodilator hydrogen peroxide during reactive hyperemia in mouse mesenteric microcirculation in vivo. Am J Physiol Heart Circ Physiol 2008; 294: H441-H448.
35. Drummond GR, Cai H, Davis ME, Ramasamy S, et al. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circulation Research 2000; 86: 347-354.
36. Cai H, Davis ME, Drummond GR, et al. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 2001; 21: 1571-1576.
37. Cai H, Li Z, Dikalov S, et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002; 277: 48311-48317.
38. Moreau R, Komeichi H, Cailmail S, et al. Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats. J Hepatol 1992; 16: 215-218.
39. Sobey CG, Heistad DD, Faraci FM. Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke 1997; 28: 2290-2295.
40. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol 2003; 285: H2255-H2263.
41. Atucha NM, Ortiz MC, Fortepiani LA, et al. Role of cyclic guanosine mono-phosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats. Hepatology 1998; 27: 900-905.
42. Singh M, Moniri NH. Reactive oxygen species are required for beta2 adrener-gic receptor-beta-arrestin interactions and signaling to ERK1/2. Biochem Pharmacol 2012; 84: 661-669.
43. Zhang Z, Hao J, Zhao Z, et al. beta-Arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis. Cell Signal 2009; 21: 1195-1206.
44. Zhao M, Wimmer A, Trieu K, et al. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J Biol Chem 2004; 279: 49259-49267.
45. Su Y, Raghuwanshi SK, Yu Y, et al. Altered CXCR2 signaling in be-ta-arrestin-2-deficient mouse models. J Immunol 2005; 175: 5396-5402.
46. Basher F, Fan H, Zingarelli B, et al. beta-Arrestin 2: a Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes. Int J Clin Exp Med 2008; 1(1): 32-41.
47. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Phys-iol Rev 2003; 83: 1325-1358.